Danimer Scientific, Inc. short interest in 2024
In 2024, Danimer Scientific, Inc.'s disclosed short interest ran from 22.73% of shares outstanding on 12 Jan 2024 to 16.94% on 31 Oct 2024, a change of -5.79 percentage points. The year's high was 22.73% on 12 Jan 2024 and its low 15.64% on 30 Aug 2024, averaging 19.04% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 40.44 days on 30 Aug 2024. Full history: Danimer Scientific, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024
2024 in figures
- Start of year
- 22.73% (12 Jan 2024)
- End of year
- 16.94% (31 Oct 2024)
- Change
- -5.79 pp
- High
- 22.73% (12 Jan 2024)
- Low
- 15.64% (30 Aug 2024)
- Average
- 19.04%
- Highest days to cover
- 40.44 (30 Aug 2024)
- SEC filings marked
- 9
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 22.73% | 16.54 | |
| 31 Jan 2024 | 22.46% | 19.81 | |
| 15 Feb 2024 | 22.33% | 20.79 | |
| 29 Feb 2024 | 21.66% | 26.30 | |
| 15 Mar 2024 | 20.87% | 21.66 | |
| 28 Mar 2024 | 20.46% | 23.90 | results (8-K), results (8-K) |
| 15 Apr 2024 | 19.26% | 20.62 | 10-K filed |
| 30 Apr 2024 | 20.27% | 36.96 | |
| 15 May 2024 | 19.55% | 24.57 | 10-Q filed, results (8-K) |
| 31 May 2024 | 19.41% | 36.89 | |
| 14 Jun 2024 | 19.73% | 33.95 | |
| 28 Jun 2024 | 19.70% | 12.55 | |
| 15 Jul 2024 | 17.96% | 19.31 | |
| 31 Jul 2024 | 16.17% | 26.79 | |
| 15 Aug 2024 | 16.49% | 26.22 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 15.64% | 40.44 | |
| 13 Sep 2024 | 15.89% | 28.94 | |
| 30 Sep 2024 | 16.35% | 23.90 | |
| 15 Oct 2024 | 16.87% | 37.85 | |
| 31 Oct 2024 | 16.94% | 34.99 |
See also: Danimer Scientific, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.